Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
AI In Clinical Trials Market Revenue Growth On Track For A 43% CAGR Through 2030
The market size for AI in clinical trials has experienced significant exponential growth in recent years. This market is projected to expand from $9.16 billion in 2025 to reach $13.08 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 42.8%. The historical expansion can be attributed to factors such as rising clinical trial complexity, increasing R&D expenditure, the demand for faster drug development, the growth in clinical data volumes, and the limitations of traditional trial methods.
The AI in clinical trials market is poised for rapid expansion over the coming years. Projections indicate it will reach $54.71 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 43.0%. Factors contributing to this growth during the forecast period include the increasing prevalence of decentralized clinical trials, greater uptake of real-world evidence, the development of precision medicine, enhanced regulatory approval for AI tools, and improvements in healthcare analytics. Key trends anticipated for this period encompass AI-driven patient acquisition, modeling for predictive trial outcomes, automated scrutiny of clinical data, the incorporation of remote patient monitoring, and the embrace of adaptive trial designs.
Get A Free Sample Report With In-Depth Market Insights:
AI In Clinical Trials Market Growth Factors: What’s Supporting Expansion?
The anticipated increase in chronic and infectious disease cases is set to boost the expansion of the AI in clinical trials market in the future. A chronic disease is defined as an ailment persisting for at least three months, with the potential to worsen over time. AI’s application in clinical trials is beneficial for creating diverse medications to manage chronic conditions. As an illustration, the UK-based Macmillan Cancer Support revealed in August 2024 that over 3 million individuals were living with cancer in the UK in 2024, a number projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the growing prevalence of chronic and infectious diseases is a key factor stimulating the growth of the AI in the clinical trials market.
AI In Clinical Trials Market Segment Breakdown: Which Categories Lead On Revenue?
The AI in clinical trials market covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
AI In Clinical Trials Market Industry Trends: What’s Reshaping Demand?
Leading companies within the AI in clinical trials market are adopting a strategic partnership approach to provide research tools and operational efficiencies, aiming for improved timelines and increased patient recruitment. Strategic partnerships involve companies utilizing each other’s strengths and resources to achieve mutual benefits and success. As an illustration, in February 2023, a US-based pharmaceutical commercial company collaborated with Haystack Health, a US-based software development company. This partnership is designed to leverage AI and Natural Language Processing (NLP) to accelerate clinical trials, enhance patient recruitment, and lower the screen failure rate by employing clinical AI and pre-screening services, which typically incur significant time and financial costs.
AI In Clinical Trials Market Leading Players And Competitive Positioning
Major companies operating in the AI in clinical trials market are ConcertAI Inc.; Owkin Inc.; AiCure Technologies Inc.; Ardigen S.A.; Unlearn.AI Inc.; PathAI Inc.; Exscientia plc; VeriSIM Life Inc.; Envisagenics Inc.; NURITAS Limited; BioSymetrics Inc.; Trials.AI Inc.; IQVIA Holdings Inc.; Euretos B.V.; Saama Technologies LLC; Deep 6 AI Inc.; Medidata Solutions Inc.; Antidote Technologies Inc.; Castor EDC B.V.; TrialSpark Inc.; Phesi S.A.; CluePoints NV
View The Full AI In Clinical Trials Market Report:
AI In Clinical Trials Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the AI in clinical trials market in 2025. The regions covered in the AI in clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
